• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在巴基斯坦人群中,与 2 型糖尿病相关的人类 SLC29A4 基因突变的临床显著发现。

Clinically significant findings of high-risk mutations in human SLC29A4 gene associated with diabetes mellitus type 2 in Pakistani population.

机构信息

Department of Bioinformatics & Biotechnology, International Islamic University (IIUI), Islamabad, Pakistan.

PMAS Arid Agriculture University, Rawalpindi, Pakistan.

出版信息

J Biomol Struct Dyn. 2022;40(23):12660-12673. doi: 10.1080/07391102.2021.1975561. Epub 2021 Sep 23.

DOI:10.1080/07391102.2021.1975561
PMID:34551672
Abstract

This study conducted an in-depth analysis combining computational and experimental verifications of the deleterious missense mutations associated with the SLC29A4 protein. The functional annotation of the non-synonymous single nucleotide polymorphism (nsSNPs), followed by structure-function analysis, revealed 13 single nucleotide polymorphisms (SNP) as the most damaging. Among these, six mutants P429T/S, L144S, M108V, N86H, and V79E, were predicted as structurally and functionally damaging by protein stability analysis. Also, these variants are located at evolutionary conserved regions, either buried, contributing to the structural damage, or exposed, causing functional changes in the protein. These mutants were further taken for molecular docking studies. When verified via experimental analysis, the SNPs M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) showed an association with type 2 diabetes mellitus (T2DM). Minor allele frequency for rs149798710 (A > G) was 0.23 in controls, 0.29 in metformin responders, 0.37 in metformin non-responder, for rs151039853 (A > C) was 0.21 in controls, 0.28 in metformin responders, 0.36 in metformin non-responder and for rs17854505 (T > A) was 0.20 in controls, 0.25 in metformin responders, 0.37 in metformin non-responder. Hence, this study concludes that SLC29A4 M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) polymorphisms were associated with the increased risk of T2DM as well as with the increased risk towards the failure of metformin therapeutic response in T2DM patients of Pakistan. Communicated by Ramaswamy H. Sarma.

摘要

本研究通过计算和实验验证相结合,深入分析了与 SLC29A4 蛋白相关的有害错义突变。对非同义单核苷酸多态性(nsSNP)进行功能注释,然后进行结构-功能分析,结果显示 13 个单核苷酸多态性(SNP)的破坏性最大。其中,P429T/S、L144S、M108V、N86H 和 V79E 这 6 个突变体被预测为通过蛋白质稳定性分析在结构和功能上具有破坏性。此外,这些变体位于进化保守区域,要么被埋藏,导致结构损伤,要么暴露,导致蛋白质功能发生变化。这些变体进一步进行了分子对接研究。当通过实验分析验证时,SNP M108V(rs149798710)、N86H(rs151039853)和 V79E(rs17854505)与 2 型糖尿病(T2DM)相关。rs149798710(A>G)的次要等位基因频率在对照组中为 0.23,在二甲双胍应答者中为 0.29,在二甲双胍无应答者中为 0.37;rs151039853(A>C)在对照组中为 0.21,在二甲双胍应答者中为 0.28,在二甲双胍无应答者中为 0.36;rs17854505(T>A)在对照组中为 0.20,在二甲双胍应答者中为 0.25,在二甲双胍无应答者中为 0.37。因此,本研究得出结论,SLC29A4 M108V(rs149798710)、N86H(rs151039853)和 V79E(rs17854505)多态性与 T2DM 的发病风险增加以及巴基斯坦 T2DM 患者二甲双胍治疗反应失败的风险增加有关。由 Ramaswamy H. Sarma 传达。

相似文献

1
Clinically significant findings of high-risk mutations in human SLC29A4 gene associated with diabetes mellitus type 2 in Pakistani population.在巴基斯坦人群中,与 2 型糖尿病相关的人类 SLC29A4 基因突变的临床显著发现。
J Biomol Struct Dyn. 2022;40(23):12660-12673. doi: 10.1080/07391102.2021.1975561. Epub 2021 Sep 23.
2
Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by ) and Organic Cation Transporter 1 (OCT1) (Encoded by ) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study.2 型糖尿病患者对二甲双胍的胃肠道不耐受与血浆膜单胺转运体(PMAT)(由 编码)和有机阳离子转运蛋白 1(OCT1)(由 编码)的变化:IMI DIRECT 研究。
Diabetes Care. 2019 Jun;42(6):1027-1033. doi: 10.2337/dc18-2182. Epub 2019 Mar 18.
3
Exploring the rare variants associated with Type 2 Diabetes Mellitus in Indian population and its disease-drug association studies: an approach.探讨与印度人群 2 型糖尿病相关的罕见变异及其与疾病相关药物的关联研究:一种方法。
J Biomol Struct Dyn. 2024 Aug;42(12):6307-6322. doi: 10.1080/07391102.2023.2233634. Epub 2023 Jul 13.
4
Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients.SLC22A2(rs201919874)和SLC47A2(rs138244461)基因变异对巴基斯坦2型糖尿病患者二甲双胍药代动力学的影响。
J Pak Med Assoc. 2019 Feb;69(2):155-163.
5
Evaluation of the rs3088442 G>A SLC22A3 Gene Polymorphism and the Role of microRNA 147 in Groups of Adult Pakistani Populations With Type 2 Diabetes in Response to Metformin.评价 rs3088442 G>A 单核苷酸多态性与 microRNA 147 在成年巴基斯坦 2 型糖尿病人群中对二甲双胍反应的作用。
Can J Diabetes. 2019 Mar;43(2):128-135.e3. doi: 10.1016/j.jcjd.2018.07.001. Epub 2018 Jul 17.
6
Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.鉴定影响 2 型糖尿病患者二甲双胍应答的临床和药物遗传学因素。
Pharmacogenomics. 2023 Aug;24(12):651-663. doi: 10.2217/pgs-2023-0109. Epub 2023 Aug 23.
7
The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 weeks follow-up study.SLC22A3 rs543159 和 rs1317652 基因变异对新诊断 2 型糖尿病患者二甲双胍治疗效果的影响:25 周随访研究。
Gene. 2022 May 20;823:146382. doi: 10.1016/j.gene.2022.146382. Epub 2022 Feb 28.
8
Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.遗传变异、差异基因表达和等位基因特异性表达对二甲双胍治疗初诊 2 型糖尿病患者的影响。
J Endocrinol Invest. 2023 Jun;46(6):1205-1218. doi: 10.1007/s40618-022-01989-y. Epub 2022 Dec 18.
9
In silico analysis of non-synonymous missense SNPs (nsSNPs) in CPE, GNAS genes and experimental validation in type II diabetes mellitus through Next Generation Sequencing.通过下一代测序对CPE、GNAS基因中的非同义错义单核苷酸多态性(nsSNPs)进行计算机分析以及在2型糖尿病中的实验验证。
Genomics. 2021 Jul;113(4):2426-2440. doi: 10.1016/j.ygeno.2021.05.022. Epub 2021 May 21.
10
Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes.人有机阳离子转运体-1(OCT-1/SLC22A1)在调节 2 型糖尿病患者对二甲双胍反应中的作用。
BMC Endocr Disord. 2022 May 26;22(1):140. doi: 10.1186/s12902-022-01033-3.

引用本文的文献

1
Heterotypic Stressors Unmask Behavioral Influences of PMAT Deficiency in Mice.异质应激源揭示了 PMAT 缺乏对小鼠行为的影响。
Int J Mol Sci. 2023 Nov 18;24(22):16494. doi: 10.3390/ijms242216494.
2
Heterotypic stressors unmask behavioral influences of PMAT deficiency in mice.异型应激源揭示了小鼠中PMAT缺乏对行为的影响。
bioRxiv. 2023 Nov 13:2023.08.30.555632. doi: 10.1101/2023.08.30.555632.
3
Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters.
总结使用组成型遗传缺陷研究摄取 2 单胺转运体对行为的影响。
Basic Clin Pharmacol Toxicol. 2023 Nov;133(5):439-458. doi: 10.1111/bcpt.13810. Epub 2022 Nov 20.
4
Uncovering Functional Contributions of PMAT () to Monoamine Clearance Using Pharmacobehavioral Tools.利用药理学行为学工具揭示 PMAT() 对单胺清除的功能贡献。
Cells. 2022 Jun 9;11(12):1874. doi: 10.3390/cells11121874.